Intellia, Keros, iTeos, Vivodyne, Merck
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your ...
Tag: Keros
Takeda Pays $200M for Keros Therapeutics Drug With Potential in Blood Cancers and Beyond
Takeda Pharmaceutical is expanding its prospects in hematology with a deal for rights to a drug advancing to pivotal testing ...
Discover the latest in health and fitness with Your Health 247. Get expert advice, workout routines, healthy recipes, and mental wellness tips to lead a healthier, happier life. Stay informed and empowered with us!